September 2024 in “BMJ Case Reports” This case report highlights an atypical presentation of favus in an immunocompetent adult, where a psoriasiform plaque over the 'bindi' area was successfully treated with systemic itraconazole, achieving complete resolution without relapse. Simple stains proved essential for diagnosis in this resource-limited setting.
August 2024 in “Australasian Journal of Dermatology” This study found that finasteride users had a very low rate of psychiatric side effects, with no significant increase in BPH patients and a slight increase in anxiety and depression among AGA patients.
August 2024 in “Clinical Cosmetic and Investigational Dermatology” In this case report, a patient with severe erythrodermic psoriasis and diffuse alopecia who was unresponsive to conventional treatments showed complete resolution of skin lesions and alopecia after being treated with ixekizumab.
August 2024 in “Polo del Conocimiento” This article discusses psoriasis, highlighting its common triggers, such as trauma and infections, and potential treatment options ranging from topical therapies to systemic medications like methotrexate for severe cases.
July 2024 in “Skin Appendage Disorders” This study reviews literature showing that trichotillomania significantly reduces quality of life and emphasizes that effective treatment requires an interdisciplinary approach involving dermatology and psychiatry to address its psychiatric component.
June 2024 in “Skin Health and Disease” This study found that most men with alopecia experience significant psychosocial concerns, such as depleted confidence and lower wellbeing, yet seldom seek support, suggesting a disconnect likely influenced by masculine norms, particularly impacting those identifying as sexual minorities.
May 2024 in “International journal of medicine and psychology.” In this article, researchers analyzed the concept of personal sovereignty in cyberspace, highlighting the lack of consensus in scientific literature and revealing that few studies focus on psychological factors affecting personal sovereignty online; it contrasts foreign terms like "confidentiality" with personal sovereignty.
April 2024 in “Research Square” This study observed that children with alopecia areata had higher anxiety and depression scores, and their families showed more neglectful parenting styles compared to healthy controls.
April 2024 in “The Journal of urology/The journal of urology” This study observed that although 5-alpha-reductase inhibitors reduce PSA density in patients on active surveillance for prostate cancer, those who progress to more serious disease still show higher PSA densities, suggesting these inhibitors accentuate differences in clinically significant cases.
In this case report, researchers observed that a malnourished male patient developed pseudoglucagonoma syndrome, characterized by necrolytic migratory erythema and diffuse hair loss, following Frey's surgery, which rapidly improved with enhanced nutrition.
April 2024 in “Cosmetics” In this review, the authors explore how wigs can significantly improve the quality of life for individuals with alopecia areata by providing emotional benefits and serving as a coping mechanism for hair loss, while also addressing economic considerations and potential barriers to their use.
April 2024 in “Meždunarodnyj vestnik veterinarii” In a study conducted on a beef-producing farm, "Deltsid 7.5" was found to be the most effective treatment for psoroptic scab in cattle, eradicating acarian phases and restoring skin and hair by 28 days, outperforming macrocyclic lactone treatments.
March 2024 in “Ukraïnsʹkij vìsnik psihonevrologìï” This study found that among women with diffuse alopecia, 47.7% exhibited psychopathological symptoms, with mixed alopecia patients showing more severe manifestations compared to those with metabolic alopecia, suggesting the need for personalized management strategies.
March 2024 in “Buletin de psihiatrie integrativă (Print)” This review identifies a significant link between telogen effluvium and increased psychological distress, including anxiety, depression, and social phobia, stressing the need for both medical and psychological care to improve affected individuals' quality of life.
This study found that an extract treatment showed similar efficacy and tolerability to calcipotriol/betamethasone ointment in reducing psoriasis severity and symptoms over 28 days in patients with mild-to-moderate plaque psoriasis.
This study examined the molecular communication in psoriasis cells, highlighting unique immune cell interactions and identifying new features of the hair follicle cell-psoriasis axis. It suggests the potential for targeted therapies at the single-cell level to improve psoriasis treatment.
January 2024 in “Annals of Dermatology” This study highlights the lack of sufficient Korean epidemiological research examining the psychosocial aspects of female pattern hair loss, the leading cause of hair loss among women.
This article reviews the characteristics of alopecia areata, highlights the psychological factors involved, and discusses South American contributions to understanding the disease, but reports no new clinical results.
January 2024 in “Journal of Ayurveda Campus” In this review, researchers reported that Psoralea corylifolia, extensively used in Ayurveda and Traditional Chinese Medicine, exhibits various pharmacological activities, including antioxidant and antidiabetic effects, and is primarily used for treating skin diseases. The authors suggest further clinical trials to explore its therapeutic potential.
January 2024 in “Skin appendage disorders” In this case report, a 31-year-old diabetic and obese male was diagnosed with follicular psoriasis, a rare variant characterized by scaly follicular papules, using dermoscopy and histopathology; treatment with topical mometasone furoate and oral levocetirizine led to complete lesion resolution within a month.
January 2024 in “Medical Research Archives” This source highlights the emerging field of psychodermatology, which examines the interplay between psychological factors and skin disorders, noting a historical lack of attention due to inadequate professional training and emphasizing the need for integrated care involving dermatologists, psychiatrists, and psychologists.
This case study observed that a patient with multiple refractory inflammatory conditions, including psoriasis, alopecia areata, and psoriatic arthritis, experienced significant improvements after three months of treatment with upadacitinib. The report suggests potential benefits of upadacitinib for similar conditions, recommending further clinical trials.
December 2023 in “Journal of family medicine and primary care” This study focused on understanding the psychosocial impact of androgenetic alopecia in Saudi Arabia to potentially improve treatment strategies for hair loss by incorporating stress-coping methods and new therapeutic approaches.
December 2023 in “Current psychosomatic research” This study suggests that psychological interventions such as mindfulness therapy, yoga, cognitive-behavioral therapy, and motivational interviewing may increase the quality of life for women with polycystic ovarian syndrome.
November 2023 in “Journal of animal science/Journal of animal science ... and ASAS reference compendium” This study investigated differences in gene expression in the mammary glands of SLICK and wild-type Holstein cattle, finding limited differences overall but identifying enriched pathways related to arachidonic acid metabolism and oxytocin production, which merit further exploration.
November 2023 in “The journal of investigative dermatology/Journal of investigative dermatology” This study developed a questionnaire based on Andersen’s behavioral model to explore psychological well-being and mental health help-seeking behaviors among alopecia areata patients from underserved communities, aiming to better understand factors influencing their mental healthcare utilization.
October 2023 in “Han'gug miyong haghoeji/Journal of the Korean society of cosmetology” In this study, the researchers found that awareness of appearance due to hair loss positively impacted hair loss management behaviors through self-awareness and psychological factors, but appearance management intention did not influence care behaviors.
October 2023 in “Psychiatry research. Case reports” In this study, researchers observed that twins with a novel de novo nonsense variant in HRAS exhibited distinctive features, including neuropsychiatric symptoms, potentially indicating a wider clinical spectrum for conditions known as RASopathies.
October 2023 in “Pathology” In this study, the authors observed that a 48-year-old woman developed a cutaneous pseudolymphoma in the earlobes linked to metallic debris from ear piercing, which histologically mimicked lymphoma but was interpreted as a reactive condition.
September 2023 in “Journal of the American Academy of Dermatology” This study found that patients receiving immune checkpoint inhibitors who have a history of psoriasis are at a higher risk for developing gastrointestinal and endocrine toxicities within one year compared to those without psoriasis.